HILL MATTHEW C has filed 6 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 100000 shares of Apyx Medical Corp ($APYX) on May 15, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Apyx Medical Corp | $APYX | HILL MATTHEW C | Chief Financial Officer | A | Stock Option (Option to Buy) | 100000 | $0.00 | 100,000.0000 | 35,542,000 | 9999.99% | 0.28% |
| Aug. 13, 2024 | Apyx Medical Corp | $APYX | HILL MATTHEW C | Chief Financial Officer | P | Common Stock | 6000 | $1.13 | 8,500.0000 | 34,622,000 | 240.00% | 0.02% |
| Jan. 15, 2025 | Apyx Medical Corp | $APYX | HILL MATTHEW C | Chief Financial Officer | A | Stock Option (Option to Buy) | 50000 | $0.00 | 50,000.0000 | 35,542,000 | 9999.99% | 0.14% |
| Aug. 13, 2024 | Apyx Medical Corp | $APYX | HILL MATTHEW C | Chief Financial Officer | P | Common Stock | 5336 | $1.13 | 7,836.0000 | 34,622,000 | 213.44% | 0.02% |
| Jan. 10, 2024 | Apyx Medical Corp | $APYX | HILL MATTHEW C | Chief Financial Officer | A | Stock Option (Option to Buy) | 150000 | $0.00 | 0.0000 | 34,622,000 | 0.00% | 0.43% |
| Jan. 5, 2023 | PDS Biotechnology Corp | $PDSB | HILL MATTHEW C | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 161200 | $0.00 | 161,200.0000 | 0 | 9999.99% | 0.00% |